Table 2.
Crude and adjusted all-cause mortality hazard ratios according to aOxCL levels (per log increase) in 221 prevalent HD patients
| All-cause mortality | CVD mortality | ||||
|---|---|---|---|---|---|
| Number of deaths | 109 (49%) | 44 (20%) | |||
| Covariates | HR (95% CI) | P | HR (95% CI) | P | |
| Crude | aOxCL-IgM (per log increase) | 0·58 (0·41–0·81) | 0·002 | 0·49 (0·30–0·82) | 0·008 |
| Adjusted | aOxCL-IgM (per log increase) | 0·62 (0·43–0·89) | 0·009 | 0·56 (0·32–0·98) | 0·04 |
| Age (years) | 1·05 (1·03–1·07) | <0·0001 | 1·03 (1·01–1·06) | 0·03 | |
| Male | 1·13 (0·76–1·69) | 0·54 | 1·01 (0·54–1·92) | 0·92 | |
| Smoking (yes) | 1·64 (0·83–3·24) | 0·06 | 2·51 (0·97–6·58) | 0·05 | |
| Vintage (months) | 1·01 (0·99–1·02) | 0·43 | 1·01 (0·99–1·01) | 0·80 | |
| Comorbidities (Davies score) | 2·16 (1·56–3·01) | 0·003 | 2·58 (1·54–4·46) | 0·0002 | |
HR: hazard ratio; aOxCL: oxidized autoantibodies against cardiolipin; Ig: immunoglobulin.